Evidence map›Paper›PMID 41303662›Full record

ArticleInternational journal of molecular sciences2025

Enhanced Antibacterial and Anti-Inflammatory Activities of the Combination of

Naruemon Perstwong, Wongsakorn Phongsopitanun, Visarut Buranasudja, Sornkanok Vimolmangkang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Naruemon PerstwongGraduate Program in Pharmaceutical Science and Technology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0009-0004-5203-7187
Wongsakorn PhongsopitanunDepartment of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
Visarut BuranasudjaDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-3582-5980
Sornkanok VimolmangkangResearch Cluster for Cannabis and Its Natural Substances, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-1705-6217

Funding

National Research Council of Thailand N41A650171Nova Health Co., Ltd. N41A650171
6 · The paper itself

Abstract

Sore throat, commonly associated with pharyngitis and tonsillitis, is primarily caused by bacterial pathogens. Conventional therapies rely on antibiotics and anti-inflammatory drugs; however, concerns about adverse effects, antibiotic resistance, and drug interactions have encouraged the search for alternative remedies.

Indexed as

Anti-Bacterial AgentsAnti-Inflammatory AgentsCannabisPlant ExtractsPropolisAnimalsCytokinesDrug SynergismMacrophagesMiceMicrobial Sensitivity TestsPseudomonas aeruginosaRAW 264.7 CellsStaphylococcus aureusStreptococcus pyogenesAnti-Bacterial AgentsAnti-Inflammatory AgentsCytokinesPlant ExtractsPropolisadditive effectcannabinoidsCBDcombination therapyhemp extract

Identifiers

PMID41303662
PMCPMC12652737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.